Publication | Open Access
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
84
Citations
24
References
2010
Year
Combination treatment with sorafenib and erlotinib or cetuximab has synergistic antitumor effects in human colorectal and lung cancer cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1